Pharmaceutical Sovereignty: the New Stake of the Mexican Industry

El Financiero

Lean Right

Factuality

Ownership

At a time when Mexico discusses its role in the global reconfiguration of supply chains, the national pharmaceutical industry begins to move parts with a different logic: less discourse and more silent capacity building. Luz Astrea Ocampo Gutiérrez de Velasco's arrival at the presidency of the Mexican Association of Pharmaceutical Laboratories (Amelaf) is no longer a relay in the sector. It represents, in fact and in “women's time”, an attempt t…